Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eisai Teams With Accenture In India For Clinical Data Management

This article was originally published in PharmAsia News

Executive Summary

Following the growing trend of outsourcing primary operational functions, Eisai announced Feb. 13 a collaborative effort with Accenture to manage Eisai's Japan, U.S., and European Union clinical data from Accenture's Chennai, India-based delivery center

You may also be interested in...



Time Has Come For Outsourcing Clinical Data Management – DIA Japan

TOKYO - To curb soaring worldwide research and development costs, pharmaceutical companies need to outsource "basically anything that can be pushed down the fiber optic cable," including clinical data management, Ron Fitzmartin, vice president, Informatics and Knowledge Management for New Jersey-based Daiichi Sankyo Pharma Development, told a Drug Information Association conference

Japanese Pharma Majors Expanding Into India

NEW DELHI - Faced with margin pressures elsewhere, pharmaceutical multinationals have been eyeing the burgeoning Indian market ever since the country signed the Trade-Related Aspects of Intellectual Property Rights pact. Initially hesitant, Japanese pharma companies are now following in the footsteps of Western companies, using India as a hub for low-cost contract manufacturing and clinical trials

Bristol/Accenture Launch Pharmacovigilance Center In India

Bristol-Myers Squibb and Accenture have established a center for pharmacovigilance as part of Accenture's Life Sciences Centers of Excellence in Chennai, India, Accenture announced Sept. 13

Related Content

UsernamePublicRestriction

Register

WI964844

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel